Načítá se...
ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers
Aggressive neuroendocrine lung cancers, including small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), represent an understudied tumor subset that accounts for approximately 40,000 new lung cancer cases per year in the United States. No targeted therapy exists for these tumors. We d...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
National Academy of Sciences
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4205603/ https://ncbi.nlm.nih.gov/pubmed/25267614 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1410419111 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|